Avacc 5
Alternative Names: Avacc-5; Enterovirus D68 vaccine - Intravacc; EV-D68 vaccineLatest Information Update: 27 Feb 2024
At a glance
- Originator Intravacc
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Acute flaccid myelitis; Paralysis
Most Recent Events
- 27 Feb 2024 Avacc 5 is available for licensing as of 27 Feb 2024. https://www.intravacc.nl/services/pipeline
- 27 Feb 2024 Preclinical trials in Acute flaccid myelitis (Prevention) in Netherlands (unspecified route), prior to February 2024 (Intravacc pipeline, February 2024)
- 27 Feb 2024 Preclinical trials in Paralysis (Prevention) in Netherlands (unspecified route), prior to February 2024 (Intravacc pipeline, February 2024)